New research suggests an easy-to-measure brain process may be a target or biomarker in measuring treatment outcomes in clinical trials for patients with Batten disease.
Researchers at the Del Monte Institute for Neuroscience at the University of Rochester find that microglia—the brain’s immune cells—can trigger cognitive deficits after radiation exposure and may be ...
The study demonstrates that calcium and chloride channelopathy lies at the heart of the muscle dysfunction found in the disease and that common clinically available calcium channel blockers can ...
Lauren Ghazal, PhD, FNP-BC, found out she had lymphoma at age 26 while working as a nurse practitioner in New York City. The experience ended up shaping her research career; today, she is part of ...
Wilmot Cancer Institute will receive $339,850 from Empire State Development (ESD) to help with renovations and new technology for their Biobank Shared Resource. The grant was awarded through the ...
Wilmot investigator Brendan Guercio, MD, is at the forefront of investigating whether a high-fiber diet can boost the effectiveness of cancer immunotherapies for patients with bladder or kidney ...